Tandem versus single autologous peripheral blood stem cell transplantation as post-remission therapy in adult acute myeloid leukemia patients under 60 in first complete remission: results of the multicenter prospective phase III GOELAMS LAM-2001 trial.
Chevallier
P
P
Fornecker
L
L
Lioure
B
B
Béné
M C
MC
Pigneux
A
A
Recher
C
C
Witz
B
B
Fegueux
N
N
Bulabois
C-E
CE
Daliphard
S
S
Bouscary
D
D
Vey
N
N
Delain
M
M
Bay
J-O
JO
Turlure
P
P
Bernard
M
M
Himberlin
C
C
Luquet
I
I
Ifrah
N
N
Harousseau
J-L
JL
D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D015331:Cohort Studies; D003131:Combined Modality Therapy; D003630:Daunorubicin / Q000008:administration & dosage; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D036102:Peripheral Blood Stem Cell Transplantation; D011446:Prospective Studies; D012074:Remission Induction; D015996:Survival Rate; D014182:Transplantation, Autologous; D016896:Treatment Outcome; D055815:Young Adult
D015255:Idarubicin; D003630:Daunorubicin